[1] Supparatpinyo K,Khamwan C,Baosoung V,et al.Disseminated Penicillium marneffei infection in southeast Asia[J].Lancet,1994,344(8915):110-113. [2] Ferdinandos SK,Marina SM,Kenneth MM,et al.Penicillium marneffei:a pathogen on our doorstep[J] ? J R Soc Med,2004,97(8):394-396. [3] Wu TC,Chan JW,Ng CK,et al.Clinical presentations and outcomes of Penicillium marneffei infections:a series from 1994 to 2004[J].Hong Kong Med J,2008,14(2):103-109. [4] Vanittanakom N,Cooper CR Jr,Fisher MC,et al.PeniciUium marneffei infection and recent advances in the epidemiology and molecular biology aspects[J].Clin Microbiol Rev,2006,19(1):95-110. [5] 侯幼红.马尔尼菲青霉的研究现状[J].中国真菌学杂志,2007,2(1):49-51. [6] 宋伟南,曾泳而,陈万山.马尔尼菲青霉菌在艾滋病人中感染状况及药敏结果分析[J].中华医药杂志,2005,5(3):728. [7] Ungpakorn R.Cutaneous manifestations of Penicillium marneffei infection[J].Curt Opin lnf Dis,2000,13(2):129-134. [8] Sirisanthana T.Pennicillium marneffei infection patients with AIDS[J].Emerg Infect Dis,2001,7(suppl):561. [9] Wong SS,Wong KH,Hui WT,et al.Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus(HIV)-and non-HIV-infected patients[J].J Clin Microbiol,2001,39(12):4535-4540. [10] Cao L,Chan KM,Chen D,et al.Detection of cell wall mannoprotein Mplp in culture supernatants of PeniciUium marneffei and in sera of penicilliosis patients[J].J Clin Microbiol,1999,37(4):981-986. [11] Sirisanthana T,Supparatpinyo K,Perriens J,et al.Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients[J].Clin Infect Dis,1998,26(5):1107-1110. [12] Supparatpinyo K,Nelson KE,Merz WG,et al.Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens[J].Antimicrob Agents Chemother,1993,37(11):2407-2411. |